Article ; Online: Increased antimicrobial resistance during the COVID-19 pandemic.
International journal of antimicrobial agents
2021 Volume 57, Issue 4, Page(s) 106324
Abstract: In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the current status of the COVID-19 (coronavirus disease 2019) pandemic. ... ...
Abstract | In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the current status of the COVID-19 (coronavirus disease 2019) pandemic. There has been a rapid increase in multidrug-resistant organisms (MDROs), including extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae, carbapenem-resistant New Delhi metallo-β-lactamase (NDM)-producing Enterobacterales, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus (MRSA), pan-echinocandin-resistant Candida glabrata and multi-triazole-resistant Aspergillus fumigatus. The cause is multifactorial and is particularly related to high rates of antimicrobial agent utilisation in COVID-19 patients with a relatively low rate of co- or secondary infection. Appropriate prescription and optimised use of antimicrobials according to the principles of antimicrobial stewardship as well as quality diagnosis and aggressive infection control measures may help prevent the occurrence of MDROs during this pandemic. |
---|---|
MeSH term(s) | Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Antimicrobial Stewardship ; Bacteria/drug effects ; Bacterial Infections/complications ; Bacterial Infections/drug therapy ; Bacterial Infections/epidemiology ; COVID-19/complications ; COVID-19/epidemiology ; Coinfection/drug therapy ; Coinfection/epidemiology ; Drug Resistance, Microbial ; Drug Utilization ; Fungi/drug effects ; Humans ; Incidence ; Mycoses/complications ; Mycoses/drug therapy ; Mycoses/epidemiology ; Pandemics |
Chemical Substances | Anti-Bacterial Agents |
Language | English |
Publishing date | 2021-03-19 |
Publishing country | Netherlands |
Document type | Journal Article ; Review |
ZDB-ID | 1093977-5 |
ISSN | 1872-7913 ; 0924-8579 |
ISSN (online) | 1872-7913 |
ISSN | 0924-8579 |
DOI | 10.1016/j.ijantimicag.2021.106324 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3368: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 500: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.